Earnings Call · Q2 FY2023·2023-08-03

Q2 23EPS -20.90%·Rev n/aQ1 23EPS +25.87%·Rev n/aQ4 22EPS +11.58%·Rev n/aQ3 22EPS -14.49%·Rev n/a⚠ consensus missing

ALNYLAM PHARMACEUTICALS, INC. ALNY

Christine Lindenboom — Senior Vice President of Investor Relations and Corporate Communications

Yvonne Greenstreet — Chief Executive Officer

Tolga Tanguler — Chief Commercial Officer

Pushkal Garg — Chief Medical Officer

Jeff Poulton — Chief Financial Officer

+1.7%1d on move date+1.9% vs SPY3d−1.5%5d−0.3%

Research tier

Behavioral profile computed for 5 speakers on this call.

Sign in to view the Behavioral Lean, the Behavioral Deviation Score, the speaker decomposition, and the novel forward-guidance phrases flagged on this call — each scored against the speaker's own prior-call baseline.

Behavioral data on every earnings call

Per-speaker language deviation, scored against each executive's own history. Explore more ALNY calls or request research access.

More ALNY calls Browse calls Request research access